Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 May 9:361:k1551.
doi: 10.1136/bmj.k1551.

Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial

Cristina E Firanescu  1 , Jolanda de Vries  2   3 , Paul Lodder  3 , Alexander Venmans  2 , Marinus C Schoemaker  2 , Albert J Smeets, Esther Donga  2 , Job R Juttmann  2 , Caroline A H Klazen  4 , Otto E H Elgersma  5 , Frits H Jansen  6 , Alexander V Tielbeek  6 , Issam Boukrab  2 , Karen Schonenberg  2 , Willem Jan J van Rooij  2 , Joshua A Hirsch  7 , Paul N M Lohle  2
Affiliations
Randomized Controlled Trial

Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial

Cristina E Firanescu et al. BMJ. .

Erratum in

Abstract

Objective: To assess whether percutaneous vertebroplasty results in more pain relief than a sham procedure in patients with acute osteoporotic compression fractures of the vertebral body.

Design: Randomised, double blind, sham controlled clinical trial.

Setting: Four community hospitals in the Netherlands, 2011-15.

Participants: 180 participants requiring treatment for acute osteoporotic vertebral compression fractures were randomised to either vertebroplasty (n=91) or a sham procedure (n=89).

Interventions: Participants received local subcutaneous lidocaine (lignocaine) and bupivacaine at each pedicle. The vertebroplasty group also received cementation, which was simulated in the sham procedure group.

Main outcome measures: Main outcome measure was mean reduction in visual analogue scale (VAS) scores at one day, one week, and one, three, six, and 12 months. Clinically significant pain relief was defined as a decrease of 1.5 points in VAS scores from baseline. Secondary outcome measures were the differences between groups for changes in the quality of life for osteoporosis and Roland-Morris disability questionnaire scores during 12 months' follow-up.

Results: The mean reduction in VAS score was statistically significant in the vertebroplasty and sham procedure groups at all follow-up points after the procedure compared with baseline. The mean difference in VAS scores between groups was 0.20 (95% confidence interval -0.53 to 0.94) at baseline, -0.43 (-1.17 to 0.31) at one day, -0.11 (-0.85 to 0.63) at one week, 0.41 (-0.33 to 1.15) at one month, 0.21 (-0.54 to 0.96) at three months, 0.39 (-0.37 to 1.15) at six months, and 0.45 (-0.37 to 1.24) at 12 months. These changes in VAS scores did not, however, differ statistically significantly between the groups during 12 months' follow-up. The results for secondary outcomes were not statistically significant. Use of analgesics (non-opioids, weak opioids, strong opioids) decreased statistically significantly in both groups at all time points, with no statistically significant differences between groups. Two adverse events occurred in the vertebroplasty group: one respiratory insufficiency and one vasovagal reaction.

Conclusions: Percutaneous vertebroplasty did not result in statistically significantly greater pain relief than a sham procedure during 12 months' follow-up among patients with acute osteoporotic vertebral compression fractures.

Trial registration: ClinicalTrials.gov NCT01200277.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. JAH has received consulting fees from Medtronic and Globus as well as serving on a data and safety monitoring board of a study sponsored by Codman Neurovascular.

Figures

Fig 1
Fig 1
Flow of participants through study
Fig 2
Fig 2
Mean visual analogue scale (VAS) score for participants in vertebroplasty and sham procedure groups during 12 months’ follow-up. Whiskers represent 95% confidence intervals
Fig 3
Fig 3
Kaplan-Meier survival curves for time to clinically significant pain relief (decrease of 1.5 points on visual analogue scale) from baseline in vertebroplasty and sham procedure groups. Patients who were lost to follow-up before assessment of pain relief were censored
See this image and copyright information in PMC

References

    1. Jha RM, Yoo AJ, Hirsch AE, Growney M, Hirsch JA. Predictors of successful palliation of compression fractures with vertebral augmentation: single-center experience of 525 cases. J Vasc Interv Radiol 2009;20:760-8. 10.1016/j.jvir.2009.01.037 - DOI - PubMed
    1. Voormolen MH, Lohle PN, Lampmann LE, et al. Prospective clinical follow-up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. J Vasc Interv Radiol 2006;17:1313-20. 10.1097/01.RVI.0000231952.75209.4A - DOI - PubMed
    1. Anselmetti GC, Manca A, Hirsch J, et al. Percutaneous vertebroplasty in osteoporotic patients: an institutional experience of 1,634 patients with long-term follow-up. J Vasc Interv Radiol 2011;22:1714-20. 10.1016/j.jvir.2011.09.001 - DOI - PubMed
    1. Barr JD, Jensen ME, Hirsch JA, et al. Position Statement on Percutaneous Vertebral Augmentation: A Consensus Statement. Developed by the American Association of Neurological Surgeons(AANS) and the Congress of Neurological Surgeons (CNS), American College of Radiology (ACR), American Society of Neuroradiology (ASNR), American Society of Spine Radiology (ASSR), Canadian Interventional Radiology Association (CIRA), Society of Interventional Radiology (SIR), and the Society of NeuroInterventional Surgery (SNIS). J Vasc Interv Radiol 2014;25:171-81. 10.1016/j.jvir.2013.10.001 - DOI - PubMed
    1. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361:569-79. 10.1056/NEJMoa0900563 - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data